Daclatasvir-d6 | CAS 1801709-41-0 - Request Quote
Daclatasvir-d6
| SZ CAT No: | SZ-D036D01 |
| CAS No | 1801709-41-0 |
| Mol.F. | C40H44D6N8O6 |
| Mol.Wt. | 744.9 |
| Inv. Status | Synthesis on demand |
| Rel. CAS No | 1009119-64-5 (Non-labelled) |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Daclatasvir-d6 is chemically N,N’-[[1,1’-Biphenyl]-4,4’-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]bis-carbamic Acid C,C’-Dimethyl Ester-d6;. Daclatasvir-d6 is supplied with detailed characterization data compliant with regulatory guideline. Daclatasvir-d6 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Daclatasvir.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1801709-41-0
Purchase 1801709-41-0
Order 1801709-41-0
Enquire 1801709-41-0
price of 1801709-41-0
1801709-41-0 Supplier
1801709-41-0 Manufacturer
1801709-41-0 Exporter
buy high quality Daclatasvir-d6
Purchase Daclatasvir-d6
Daclatasvir-d6 suppliers
Daclatasvir-d6 manufacturers
Daclatasvir-d6 price
Order Daclatasvir-d6
Enquire Daclatasvir-d6
Daclatasvir-d6 cost
Daclatasvir-d6 Supplier
Daclatasvir-d6 Distributor
Daclatasvir-d6 for Method Validation
Daclatasvir Reference Standard
Daclatasvir-d6 for ANDA Filing
Daclatasvir-d6 for Forced Degradation Studies
Daclatasvir-d6 Identification Standards
Daclatasvir-d6 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.